SUMMARY OF INTENSIVE MANAGEMENT OF TYPE 2 DIABETES: CARDIOVASCULAR DISEASE
Thursday, December 23rd, 2010Type 2 diabetes is characterized by accelerated cardiovascular disease. The risk for myocardial infarction, cardiovascular death, strokes, and peripheral vascular insufficiency is increased at least 2- to 4-fold in people with type 2 diabetes. These risks are doubled in African, Hispanic, and Mexican Americans and are magnified in a profound way by hypertension, dyslipidemia, cigarette smoking, and a prothrombotic state, which often is seen in type 2 diabetes. In particular, before the appearance of fasting hyperglycemia, many type 2 patients have had years of a metabolic syndrome, which confers a high cardiovascular risk. In this syndrome, glucose intolerance may be mild (or absent), but hypertension, microalbuminuria, low plasma HDL-C and high triglyceride levels, increased concentrations of atherogenic small, dense LDL particles, altered platelet function, diminished fibrinolytic activity and insulin resistance with hyperinsulinemia are present in various combinations. The net effect is that people with type 2 diabetes have a high cardiovascular risk from a variety of factors that are active even before fasting hyperglycemia and frank diabetes are apparent. Thus, a program of prevention of progression of accelerated atherothrombosis, which starts even before the diagnosis of type 2 diabetes is made, is the hallmark of intensive management of type 2 diabetes. A multifactorial approach that not only includes intensive glycemic regulation but also aggressively addresses multiple cardiovascular risk factors is indicated.
The goals of therapy are the same as in type 1 diabetes (see previous section). However, testing and preventive therapy for accelerated cardiovascular disease must proceed at an earlier stage in type 2 than in type 1 diabetes.
*237\357\8*